By vgreene, 12 October, 2021 Non pregnant women of childbearing potential who are sexually active or have been sexually assaulted and who are not using an effective birth control method and
By vgreene, 12 October, 2021 CDC s latest interim guidance recommends against use of dolutegravir DTG for
By vgreene, 12 October, 2021 Health care providers seeking advice can call the National Clinical Consultations Center s PEPline at 888 448 4911
By vgreene, 12 October, 2021 If PEP regimen for a non pregnant woman of childbearing potential must include DTG advise pt to use an effective birth control method until PEP regimen completed
By vgreene, 12 October, 2021 However CDC acknowledges that individual circumstances may dictate consideration of alternatives eg raltegravir is not available
By vgreene, 12 October, 2021 Pregnant women early in pregnancy since risk of an unborn infant developing a neural tube defect is during the first 28 days
By vgreene, 12 October, 2021 Non pregnant women of childbearing potential who are sexually active or have been sexually assaulted and who are not using an effective birth control method and
By vgreene, 12 October, 2021 CDC s latest interim guidance recommends against use of dolutegravir DTG for
By vgreene, 12 October, 2021 Health care providers seeking advice can call the National Clinical Consultations Center s PEPline at 888 448 4911
By vgreene, 12 October, 2021 If PEP regimen for a non pregnant woman of childbearing potential must include DTG advise pt to use an effective birth control method until PEP regimen completed
